Related Experiment Video
Updated: Jul 6, 2025

A Proximal Culture Method to Study Paracrine Signaling Between Cells
Published on: August 28, 2018
Intercellular crosstalk shapes purinergic metabolism and signaling in cancer cells
Julia Hesse1, Bodo Steckel2, Peter Dieterich3
1Department of Molecular Cardiology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany; CARID, Cardiovascular Research Institute Düsseldorf, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany.
Abstract:
CD73-derived adenosine suppresses anti-cancer immunity, and CD73 inhibitors are currently evaluated in several clinical trials. Here, we have assessed enzyme kinetics of all key purinergic ectoenzymes in five cancer cell lines (Hodgkin lymphoma, multiple myeloma, pancreas adenocarcinoma, urinary bladder carcinoma, and glioblastoma) under normoxia and hypoxia. We found that adenosine metabolism varied considerably between individual cancer types. All cell lines investigated exhibited high ecto-adenosine deaminase (ADA) activity, which critically influenced the kinetics of adenosine accumulation. Combining kinetics data with single-cell RNA sequencing data on myeloma and glioblastoma cancerous tissue revealed that purine metabolism is not homogeneously organized, but it differs in a cancer type-specific fashion between malignant cells, stromal cells, and immune cells. Since purine metabolism in cancerous tissue is most likely spatially heterogeneous and differs between the various cell types, diffusion distances in the microenvironment as well as ADA activity may be important variables that influence the level of bioactive adenosine.
Insights
Adenosine metabolism varies by cancer type, influenced by ecto-adenosine deaminase (ADA) activity. This purine metabolism heterogeneity impacts anti-cancer immunity and may affect CD73 inhibitor efficacy.
Area of Science:
- Biochemistry
- Cancer Biology
- Immunology
Background:
- CD73 generates adenosine, suppressing anti-cancer immunity.
- CD73 inhibitors are under clinical investigation for cancer therapy.
Purpose of the Study:
- To investigate purine ectoenzyme kinetics across diverse cancer cell lines.
- To understand how hypoxia and cancer type influence adenosine metabolism.
- To correlate purine metabolism with immune cell interactions in the tumor microenvironment.
Main Methods:
- Assessed enzyme kinetics of purinergic ectoenzymes in five cancer cell lines (Hodgkin lymphoma, multiple myeloma, pancreas adenocarcinoma, urinary bladder carcinoma, glioblastoma) under normoxia and hypoxia.
- Combined enzyme kinetics data with single-cell RNA sequencing data from myeloma and glioblastoma tissues.
- Analyzed purine metabolism heterogeneity across malignant, stromal, and immune cells.
Main Results:
- Significant variation in adenosine metabolism was observed among different cancer types.
- High ecto-adenosine deaminase (ADA) activity was prevalent across all tested cell lines, impacting adenosine accumulation kinetics.
- Purine metabolism exhibited cancer type-specific spatial heterogeneity within the tumor microenvironment, differing between malignant, stromal, and immune cells.
Conclusions:
- Adenosine metabolism is highly variable and cancer type-specific.
- Ecto-adenosine deaminase (ADA) activity and spatial heterogeneity are critical factors influencing bioactive adenosine levels in the tumor microenvironment.
- These findings have implications for the efficacy of CD73-targeted cancer immunotherapies.
More Related Videos
09:52A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication
Published on: September 20, 2016
09:18Heteromulticellular Stromal Cells in Scaffold-free 3D Cultures of Epithelial Cancer Cells to Drive Invasion
Published on: April 4, 2025
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Tumor Microenvironment
Mitogens and the Cell Cycle
Autocrine Signaling
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...